Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer
Emilie Laude(Institut Curie), Thomas Gaillard(Centre Hospitalier Universitaire d'Angers), E Laas(Institut Curie), Jonathan Sabah(Institut Curie), Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Lounes Djerroudi(Memorial Sloan Kettering Cancer Center), Louna Mossino Diaz(Institut Curie), J Y Pierga(Université Paris Cité), Claire Bonneau(Institut Curie), Katia Mahiou(Institut Curie), Pierre Loap(Institut Curie), Toulsie Ramtohul(Université Paris Sciences et Lettres), Celian Guyon(Institut Curie), Hélène Didelot(Institut Curie)
Cited by 0
Related Papers
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
|Breast Cancer Research|2020|125
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers
|Radiology|2023|122
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
|JNCI Cancer Spectrum|2020|60